These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 22772696)

  • 1. Use of aripiprazole in treatment of cannabis dependence in a patient presenting with Borderline Personality Disorder.
    Geoffroy PA; Rolland B; Guardia D; Warembourg F; Cottencin O
    J Neuropsychiatry Clin Neurosci; 2012; 24(2):E37. PubMed ID: 22772696
    [No Abstract]   [Full Text] [Related]  

  • 2. Aripiprazole diminishes cannabis use in schizophrenia.
    Desseilles M; Mathot F; Desseilles M
    J Neuropsychiatry Clin Neurosci; 2008; 20(1):117-8. PubMed ID: 18305305
    [No Abstract]   [Full Text] [Related]  

  • 3. Aripiprazole in a therapy-resistant patient with borderline personality and post-traumatic stress disorder.
    Kellner M
    Pharmacopsychiatry; 2007 Jan; 40(1):41. PubMed ID: 17327963
    [No Abstract]   [Full Text] [Related]  

  • 4. Aripiprazole treatment of patients with borderline personality disorder.
    Nickel MK
    J Clin Psychiatry; 2007 Nov; 68(11):1815-6. PubMed ID: 18052583
    [No Abstract]   [Full Text] [Related]  

  • 5. Aripiprazole for treating cannabis-induced psychotic symptoms in ultrahigh-risk individuals.
    Rolland B; Geoffroy PA; Jardri R; Cottencin O
    Clin Neuropharmacol; 2013; 36(3):98-9. PubMed ID: 23673914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aripiprazole in the treatment of patients with borderline personality disorder: a double-blind, placebo-controlled study.
    Nickel MK; Muehlbacher M; Nickel C; Kettler C; Pedrosa Gil F; Bachler E; Buschmann W; Rother N; Fartacek R; Egger C; Anvar J; Rother WK; Loew TH; Kaplan P
    Am J Psychiatry; 2006 May; 163(5):833-8. PubMed ID: 16648324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aripiprazole pharmacotherapy of borderline personality disorder.
    Mobascher A; Mobascher J; Schlemper V; Winterer G; Malevani J
    Pharmacopsychiatry; 2006 May; 39(3):111-2. PubMed ID: 16721700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of aripiprazole augmentation in sertraline-resistant patients with borderline personality disorder.
    Bellino S; Paradiso E; Bogetto F
    Psychiatry Res; 2008 Nov; 161(2):206-12. PubMed ID: 18848360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aripiprazole in treatment of borderline patients, part II: an 18-month follow-up.
    Nickel MK; Loew TH; Pedrosa Gil F
    Psychopharmacology (Berl); 2007 May; 191(4):1023-6. PubMed ID: 17318503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacotherapy in the treatment of borderline personality disorder].
    Alliani D; Tarantelli S
    Riv Psichiatr; 2009; 44(6):357-73. PubMed ID: 20218215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does aripiprazole protect from serotonin syndrome?
    Rittmannsberger H; Werl R
    Psychiatr Danub; 2012 Mar; 24(1):100-1. PubMed ID: 22447095
    [No Abstract]   [Full Text] [Related]  

  • 12. Advanced pediatric psychopharmacology.
    Vito J; Jummani R; Coffey B
    J Child Adolesc Psychopharmacol; 2006 Aug; 16(4):498-502. PubMed ID: 16958576
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical potentialities and perspectives for the use of aripiprazole in other disorders than its classical indications. A critical analysis of the recent literature].
    Crocq MA; Camus V; Millet B; Gliskman J; Azorin JM; Krebs MO; Limosin F; Costentin J; Daléry J
    Encephale; 2008 Apr; 34(2):187-93. PubMed ID: 18597728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aripiprazole treatment for coprophagia in autistic disorder.
    Pardini M; Guida S; Gialloreti LE
    J Neuropsychiatry Clin Neurosci; 2010; 22(4):451-s.e33-451.e33. PubMed ID: 21037151
    [No Abstract]   [Full Text] [Related]  

  • 15. Aripiprazole is effective in the treatment of Tourette's disorder.
    Constant EL; Borras L; Seghers A
    Int J Neuropsychopharmacol; 2006 Dec; 9(6):773-4. PubMed ID: 16734937
    [No Abstract]   [Full Text] [Related]  

  • 16. Aripiprazole for relapse prevention and craving in alcohol-dependent subjects: results from a pilot study.
    Janiri L; Martinotti G; Di Nicola M
    J Clin Psychopharmacol; 2007 Oct; 27(5):519-20. PubMed ID: 17873691
    [No Abstract]   [Full Text] [Related]  

  • 17. Aripiprazole as monotherapy at bedtime was effective for treatment of two cases of obsessive-compulsive disorder and insomnia.
    Takaki M
    J Neuropsychiatry Clin Neurosci; 2014; 26(3):E64. PubMed ID: 25093799
    [No Abstract]   [Full Text] [Related]  

  • 18. Effectiveness of aripiprazole in treatment of adults with attention deficit disorder and restless legs syndrome.
    Kikukawa S
    Int J Neuropsychopharmacol; 2008 May; 11(3):439-40. PubMed ID: 18208634
    [No Abstract]   [Full Text] [Related]  

  • 19. Aripiprazole in the treatment of bipolar disorder in children and adolescents.
    Durkin JP
    J Child Adolesc Psychopharmacol; 2004; 14(4):505-6. PubMed ID: 15662141
    [No Abstract]   [Full Text] [Related]  

  • 20. Reversible elevation of triglycerides in dual-diagnosis patients taking aripiprazole: a case series.
    Tolliver BK; McRae AL; Verduin ML; Anderson SJ; Brady KT
    J Clin Psychopharmacol; 2008 Aug; 28(4):464-7. PubMed ID: 18626281
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.